neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with AML.” 12 The listed side effects, with at least 2% difference in incidence, compared with placebo include epistaxis, back pain, pain
Search Results
Jacqueline N. Poston and Pamela S. Becker
Rohan Maniar, Stephanie M. Gallitano, Sameera Husain, Golnaz Moazami, Michael J. Weiss, and Catherine A. Shu
upper extremity. The lesions were intermittent and occasionally accompanied by low-grade fevers. A skin biopsy of the thigh revealed mild perivascular and subcutaneous infiltrate of lymphocytes and few neutrophils consistent with neutrophilic dermatosis
John A. Thompson, Bryan J. Schneider, Julie Brahmer, Amaka Achufusi, Philippe Armand, Meghan K. Berkenstock, Shailender Bhatia, Lihua E. Budde, Saurin Chokshi, Marianne Davies, Amro Elshoury, Yaron Gesthalter, Aparna Hegde, Michael Jain, Benjamin H. Kaffenberger, Melissa G. Lechner, Tianhong Li, Alissa Marr, Suzanne McGettigan, Jordan McPherson, Theresa Medina, Nisha A. Mohindra, Anthony J. Olszanski, Olalekan Oluwole, Sandip P. Patel, Pradnya Patil, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Vlad G. Zaha, Megan Lyons, Mary Dwyer, and Lisa Hang
outpatient transplant experience. Hospitalization is warranted for patients at the first sign of CRS or neurotoxicity, including fever, hypotension, or change in mental status. Complete blood count, complete metabolic panel (including magnesium and phosphorus
Harold J. Burstein
scientific factors centered on cancer. A century ago, infectious disease was the specialty du jour. New technologies led to life-changing discoveries: the causes of exotic illnesses like yellow fever; the introduction of antibiotics (or as it was called early
Peter F. Coccia
?”; “You feel warm; let’s take your temperature.”; “You have a fever; we are going to the emergency room.” I further think that having a reliable support system (eg, mothers, spouses, significant others, friends) has a major influence on outcomes of therapy
Margaret Tempero
something this simple, just think about how difficult it must be for our patients to master the pharmacopeia required for complex chemotherapy or symptom management drugs, not to mention remembering what to do in case of fever or a myriad of other
Gary H. Lyman and Jessica Malone Kleiner
– 4311 . 7. Crawford J Ozer H Stoller R . Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer . N Engl J Med 1991 ; 325 : 164 – 170 . 8
Pelin Cinar, Timothy Kubal, Alison Freifeld, Asmita Mishra, Lawrence Shulman, James Bachman, Rafael Fonseca, Hope Uronis, Dori Klemanski, Kim Slusser, Matthew Lunning, and Catherine Liu
symptoms such as a new or worsening cough within the past 14 days, shortness of breath, muscle aches, or fever, and may also include assessment of exposure risk, including travel history or exposure to a COVID-19–positive individual. If any concerning
Gary H. Lyman
R . Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer . N Engl J Med 1991 ; 325 : 164 – 170 . 18 Trillet-Lenoir V Green J Manegold C
Samuel L. Aitken, Jerod L. Nagel, Lilian Abbo, William Alegria, Jason N. Barreto, Sanjeet Dadwal, Alison G. Freifeld, Rupali Jain, Steven A. Pergam, Frank P. Tverdek, Susan K. Seo, and on behalf of the Antimicrobial Stewardship in Cancer Consortium ASCC
-specific, evidence-based guidelines and clinical pathways to standardize prescribing is not only feasible but necessary. Examples of highly used pathways in patients with cancer include the management of fever and neutropenia, antifungal prophylaxis and treatment
